SOLIGENIX, INC. — Form 8-K
Filed September 21, 2026 · analyzed by the 8-K Agent
8-K
— Neutral
significance 28/100
What the filing says
On September 17, 2026, Soligenix filed a Certificate of Amendment increasing total authorized capital stock to 125,350,000 shares: 125,000,000 common shares ($0.001 par), 230,000 preferred shares ($0.001 par), 10,000 Series B convertible preferred shares ($0.05 par), 10,000 Series C convertible preferred shares ($0.05 par), and 100,000 Series A junior participating preferred shares ($0.001 par). The prior authorized capital structure is not disclosed in this filing, so the magnitude of the increase cannot be quantified.
Why this rating
Charter amendment is routine corporate housekeeping. Without disclosure of prior authorized shares, the dilution impact is unclear. For a $4.6M company, authorization alone (without issuance) has minimal immediate impact.
See more from September 21, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.